Cargando…
Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy
Cardiac failure is a major cause of mortality in patients with Duchenne muscular dystrophy (DMD). Antisense-mediated exon skipping has the ability to correct out-of-frame mutations in DMD to produce truncated but functional dystrophin. Traditional antisense approaches have however been limited by th...
Autores principales: | Blain, Alison M., Greally, Elizabeth, McClorey, Graham, Manzano, Raquel, Betts, Corinne A., Godfrey, Caroline, O’Donovan, Liz, Coursindel, Thibault, Gait, Mike J., Wood, Matthew J., MacGowan, Guy A., Straub, Volker W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005479/ https://www.ncbi.nlm.nih.gov/pubmed/29912990 http://dx.doi.org/10.1371/journal.pone.0198897 |
Ejemplares similares
-
Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
por: Betts, Corinne A, et al.
Publicado: (2019) -
A comparison of the bone and growth phenotype of mdx, mdx:Cmah(−/−) and mdx:Utrn(+/−) murine models with the C57BL/10 wild-type mouse
por: Wood, Claire L., et al.
Publicado: (2020) -
Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy
por: Roberts, Thomas C, et al.
Publicado: (2012) -
Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells
por: Lehto, Taavi, et al.
Publicado: (2014) -
Myofibrillar Lattice Remodeling Is a Structural Cytoskeletal Predictor of Diaphragm Muscle Weakness in a Fibrotic mdx (mdx Cmah(−/−)) Model
por: Ritter, Paul, et al.
Publicado: (2022)